Effect of dopamine D3 receptor blockade on renal function and glomerular size in diabetic rats

被引:10
作者
Luippold, G
Beilharz, M
Wehrmann, M
Unger, L
Gross, G
Mühlbauer, B
机构
[1] Univ Tubingen, Fac Med, Dept Pharmacol & Toxicol, D-72074 Tubingen, Germany
[2] Univ Tubingen, Fac Med, Dept Pathol, D-72074 Tubingen, Germany
[3] ABBOTT GmbH & Co KG, Neurosci Discovery Res, D-67061 Ludwigshafen, Germany
关键词
diabetes mellitus; dopamine D-3 receptors; renal hemodynamics;
D O I
10.1007/s00210-005-1030-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dopamine D-2-like receptors, including D-2, D-3, and D-4 receptors, are involved in the regulation of glomerular hyperfiltration due to diabetes mellitus. These hemodynamic alterations represent a risk factor for the later development of diabetic nephropathy. The aim of the present study was to determine whether the D-3 receptor subtype modulates the diabetes-induced increase in glomerular filtration rate (GFR) in rats. Renal function was studied in Sprague-Dawley rats 14 days after induction of a moderate diabetes mellitus (DM) by streptozotocin and in non-diabetic controls (CON). Rats were orally treated either with the peripherally acting, selective dopamine D-3 receptor antagonist BSF 135170 (BSF, 10 mg/kg per day for 2 weeks) or with vehicle (VHC). Perfusion-fixed kidneys were used for estimation of glomerular volume. In conscious rats, which were treated with BSF, the DM-induced increase in fluid intake, urinary output, and renal sodium excretion was significantly less pronounced than in the vehicle group (DM-VHC). In the clearance experiments, GFR in CON was about 0.84 +/- 0.04 ml/min per 100 g body weight. The DM-VHC group presented a significant glomerular hyperfiltration (1.09 +/- 0.04 ml/min per 100 g body weight). Treatment with BSF significantly lowered GFR towards levels of CON. The estimated glomerular volume was 0.73 +/- 0.03x10(6) mu m(3) in the CON-VHC group and 0.86 +/- 0.04x10(6) mu m(3) in the DM-VHC animals. Interestingly, treatment with BSF decreased the glomerular volume in both groups. Irrespective of BSF treatment, kidney wet weight related to body weight was about 36% higher in DM animals compared with CON animals. We conclude that dopamine D-3 receptors represent a target for the modulation of diabetes-induced glomerular hyperfiltration. Therefore, the results encourage the testing of the possible beneficial effects of long-term D-3 receptor blockade on the development of diabetic nephropathy.
引用
收藏
页码:420 / 427
页数:8
相关论文
共 36 条
[1]   Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension [J].
Asico, LD ;
Ladines, C ;
Fuchs, S ;
Accili, D ;
Carey, RM ;
Semeraro, C ;
Pocchiari, F ;
Felder, RA ;
Eisner, GM ;
Jose, PA .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03) :493-498
[2]   Pharmacological characterisation and autoradiographic localisation of a putative dopamine D-3 receptor in the rat kidney [J].
Barili, P ;
Ricci, A ;
Baldoni, E ;
Mignini, F ;
Amenta, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 338 (01) :89-95
[3]   DOPAMINE ATTENUATES THE CONTRACTILE RESPONSE TO ANGIOTENSIN-II IN ISOLATED RAT GLOMERULI AND CULTURED MESANGIAL CELLS [J].
BARNETT, R ;
SINGHAL, PC ;
SCHARSCHMIDT, LA ;
SCHLONDORFF, D .
CIRCULATION RESEARCH, 1986, 59 (05) :529-533
[4]   EFFECTS OF DOPAMINE PRODRUGS AND FENOLDOPAM ON GLOMERULAR HYPERFILTRATION IN STREPTOZOTOCIN-INDUCED DIABETES IN RATS [J].
BARTHELMEBS, M ;
VAILLY, B ;
GRIMA, M ;
VELLY, J ;
STEPHAN, D ;
FROEHLY, S ;
IMBS, JL .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 (02) :243-253
[5]   Dopamine depolarizes podocytes via a D1-like receptor [J].
Bek, M ;
Fischer, KG ;
Greiber, S ;
Hupfer, C ;
Mundel, P ;
Pavenstädt, H .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (03) :581-587
[6]   CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM [J].
BILLARD, W ;
RUPERTO, V ;
CROSBY, G ;
IORIO, LC ;
BARNETT, A .
LIFE SCIENCES, 1984, 35 (18) :1885-1893
[7]   LACK OF DISCRIMINATION BY AGONISTS FOR D-2 AND D-3 DOPAMINE-RECEPTORS [J].
BURRIS, KD ;
PACHECO, MA ;
FILTZ, TM ;
KUNG, MP ;
KUNG, HF ;
MOLINOFF, PB .
NEUROPSYCHOPHARMACOLOGY, 1995, 12 (04) :335-345
[8]   Decreased tubular uptake of L-3,4-dihydroxyphenylalanine in streptozotocin-induced diabetic rats [J].
Carranza, A ;
Karabatas, L ;
Barontini, M ;
Armando, I .
HORMONE RESEARCH, 2001, 55 (06) :282-287
[9]   Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy [J].
Cooper, ME .
DIABETOLOGIA, 2001, 44 (11) :1957-1972
[10]   EXPRESSION OF THE D-2 SUBFAMILY OF DOPAMINE-RECEPTOR GENES IN KIDNEY [J].
GAO, DQ ;
CANESSA, LM ;
MOURADIAN, MM ;
JOSE, PA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :F646-F650